Transatlantic Enforcers Working Group on Pharmaceutical Mergers: Reimagining Innovation May Have Side Effects

AuthorDesma Polydorou, Bill Batchelor and George Zacharodimos
PositionSenior Corporate Counsel, Antitrust at Pfizer Inc./Partner/Associate at Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates
Pages71-80
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT